QP-Prostate® CAD vs QUIBIM Precision Prostate (qp-Prostate)
AI Verdict
Choose QP-Prostate® CAD if…
Choose QP-Prostate® CAD if your primary focus is on the precise detection and risk scoring of clinically significant prostate cancer, leveraging advanced quantitative perfusion metrics (K trans, K ep, V e) and 3D visualization for in-depth diagnostic assessment. This cloud-based solution is particularly suited for radiologists who require detailed insights from AI trained on actual pathology/biopsy data.
View QP-Prostate® CAD →Choose QUIBIM Precision Prostate (qp-Prostate) if…
Choose QUIBIM Precision Prostate (qp-Prostate) if your clinical workflow extends beyond diagnosis to include direct support for fusion biopsy and focal therapy planning. This tool offers versatile deployment options, including on-premise, making it ideal for health systems seeking an adaptable AI solution for aggressive prostate cancer stratification and treatment pathway integration.
View QUIBIM Precision Prostate (qp-Prostate) →When considering AI tools for prostate MRI interpretation, physicians have two options from Quibim S.L.: QP-Prostate® CAD and QUIBIM Precision Prostate (qp-Prostate). Both are FDA-cleared and aim to enhance diagnostic accuracy and streamline radiology workflows for prostate cancer detection. Both tools offer automated prostate segmentation, AI-driven lesion detection, and PI-RADS compliant reporting, along with AI-QUAL™ for image quality assessment.
The key practical difference lies in their feature sets and deployment. QP-Prostate® CAD provides more extensive quantitative information, including prostate volume and dimensions, computed high b-value, and perfusion metrics (K trans, K ep, V e), alongside advanced 3D visualization. It is cloud-based with integration into standard reading environments and AI marketplaces. In contrast, QUIBIM Precision Prostate focuses on aggressive lesion detection and stratification, and offers support for both fusion biopsy and focal therapy planning, with deployment options for on-premise (standard workstation compatible) and cloud-integrated systems.
A physician prioritizing comprehensive quantitative analysis, advanced visualization, and cloud-based deployment for broader integration might lean towards QP-Prostate® CAD. Conversely, a physician seeking robust support for fusion biopsy and focal therapy planning, with the flexibility of on-premise deployment, may find QUIBIM Precision Prostate to be a more suitable choice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | QP-Prostate® CAD | QUIBIM Precision Prostate (qp-Prostate) |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Cloud-based, with integration into standard reading environments (PACS) and AI marketplaces. | On-premise (standard workstation compatible) and cloud-integrated for large health systems. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
QP-Prostate® CADTool A explicitly highlights 'Advanced viewing with 3D visualization' and 'seamless integration into PACS and fusion biopsy systems', which directly enhances the radiologist's interaction with complex anatomical data. While Tool B also integrates with PACS and supports planning, Tool A's emphasis on 3D visualization provides a more direct and comprehensive user interface enhancement for image interpretation and detailed exploration.
Clinical Value
QP-Prostate® CADTool A's description emphasizes 'Automatic lesion detection and risk scoring (High and Moderate)' and provides detailed 'Quantitative information' including specific perfusion metrics (K trans, K ep, V e). Crucially, its algorithms are 'trained on actual pathology/biopsy data' and validated in studies demonstrating 'superiority endpoint of aided radiological performance versus unaided' using biopsy as ground truth, indicating a strong foundation for diagnostic accuracy.
Pricing & Value
TieBoth Tool A and Tool B state 'Contact for pricing' or 'Contact vendor'. Without transparent pricing information or specific cost-benefit analyses, it is impossible to conduct a head-to-head comparison of their value propositions.
Enterprise Readiness
QUIBIM Precision Prostate (qp-Prostate)Both tools are FDA-cleared, HIPAA compliant, and offer BAA, demonstrating a strong regulatory and security posture. However, Tool B offers greater deployment flexibility with both 'On-premise (standard workstation compatible) and cloud-integrated for large health systems' options, which caters to a wider range of enterprise IT infrastructures and preferences compared to Tool A's primarily cloud-based deployment.
Innovation
TieBoth tools demonstrate strong innovation by leveraging AI for automated prostate MRI analysis, including segmentation, lesion detection, and the unique 'AI-QUALu2122 for automated prostate MRI image quality assessment based on PI-QUAL v2 guidelines'. The presence of AI-QUALu2122 in both, described as an 'industry-first', suggests a shared core innovation from the same company, making it difficult to distinguish one as significantly more innovative than the other.
Support & Docs
TieThe provided structured facts and web search results do not offer specific details regarding the level, quality, or availability of support and documentation for either Tool A or Tool B individually. While the company Quibim S.L. has a 'Support Center Hub', there is no basis to differentiate between the two products on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | QP-Prostate® CAD | QUIBIM Precision Prostate (qp-Prostate) |
|---|---|---|
| Name | QP-Prostateu00ae CAD | QUIBIM Precision Prostate (qp-Prostate) |
| Company | Quibim S.L. | QUIBIM S.L. |
| Tagline | Your AI solution for advanced prostate cancer detection. | Your AI solution for advanced prostate cancer detection. |
| Key Features - Lesion Detection & Risk Scoring | Automatic lesion detection and risk scoring (High and Moderate) for clinically significant prostate cancer (csPCa) | AI algorithm for detection and stratification of aggressive prostate cancer lesions |
| Key Features - Prostate Segmentation | Prostate segmentation (peripheral zone, transitional and central zone, seminal vesicles) | Automated prostate segmentation (peripheral zone, transitional/central zone, seminal vesicles) |
| Key Features - Image Quality Assessment | AI-QUALu2122 for automated prostate MRI image quality assessment based on PI-QUAL v2 guidelines | AI-QUALu2122 for automated prostate MRI image quality assessment (PI-QUAL v2 guidelines) |
| Key Features - Reporting | PI-RADS 2.1 structured report template | PI-RADS compliant structured reporting |
Videos
Demos, reviews, and walkthroughs featuring QP-Prostate® CAD and QUIBIM Precision Prostate (qp-Prostate).
Frequently Asked Questions
More Comparisons
More matchups featuring QP-Prostate® CAD or QUIBIM Precision Prostate (qp-Prostate)
Backers
Who funded each tool's parent company.